Procyon Advisors LLC Cuts Stake in Cigna Group $CI

Procyon Advisors LLC cut its stake in Cigna Group (NYSE:CI) by 74.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,071 shares of the health services provider’s stock after selling 3,069 shares during the period. Procyon Advisors LLC’s holdings in Cigna Group were worth $295,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the stock. Harbor Capital Advisors Inc. boosted its holdings in shares of Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 49 shares during the last quarter. Collier Financial acquired a new stake in shares of Cigna Group during the 3rd quarter worth $34,000. Founders Capital Management increased its holdings in shares of Cigna Group by 53.0% during the 3rd quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock worth $44,000 after buying an additional 53 shares during the last quarter. Twin Peaks Wealth Advisors LLC purchased a new position in shares of Cigna Group in the 2nd quarter worth $52,000. Finally, Measured Wealth Private Client Group LLC purchased a new position in shares of Cigna Group in the 3rd quarter worth $56,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Trading Up 1.6%

NYSE:CI opened at $265.78 on Wednesday. The business’s 50-day moving average is $277.46 and its two-hundred day moving average is $280.87. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The firm has a market capitalization of $70.04 billion, a PE ratio of 11.98, a price-to-earnings-growth ratio of 0.91 and a beta of 0.27.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. During the same quarter in the previous year, the firm posted $6.64 earnings per share. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Research analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were issued a $1.56 dividend. The ex-dividend date was Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio (DPR) is currently 28.13%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. Guggenheim reissued a “buy” rating and set a $318.00 price target on shares of Cigna Group in a research report on Monday, February 2nd. Barclays cut their price objective on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a report on Friday, February 6th. UBS Group reaffirmed a “buy” rating and issued a $375.00 price objective on shares of Cigna Group in a research note on Monday, February 9th. Truist Financial boosted their target price on Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. Finally, Mizuho set a $325.00 price target on shares of Cigna Group in a report on Friday, January 9th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $333.11.

Insider Activity at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is owned by company insiders.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.